3Glaesibaer, Clinical Research Laboratory, IS-108 Reykjavik, Iceland.
4Faculty of Medicine, University of Iceland, IS-101 Reykjavik, Iceland.
5The Laboratory in Mjodd, IS-109 Reykjavik, Iceland.
6Division of Radiation Oncology, University Hospital, 50009 Zaragoza, Spain.
7Division of Pathology, San Jorge General Hospital, 22004 Huesca, Spain.
8Royo Villanova Hospital, 500014 Zaragoza, Spain.
9University of Medicine and Pharmacy Carol Davila, 020021 Bucharest, Romania.
10National Institute of Public Health, 050463 Bucharest, Romania.
11Comprehensive Cancer Center East, 6501 BG Nijmegen, Netherlands.
12Department of Epidemiology, Biostatistics and Health Technology Assessment, Radboud University Nijmegen Medical Centre, 6500 HB Nijmegen, Netherlands.
13Department of Urology, Radboud University Nijmegen Medical Centre, 6500 HB Nijmegen, Netherlands.
14Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre, 6500 HB Nijmegen, Netherlands.
15Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
16School of Social and Community Medicine, University of Bristol, Bristol BS8 1TH, UK.
17Nuffield Department of Surgical Science, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK.
18Division of Medical Oncology, University Hospital, 50009 Zaragoza, Spain.
19Oncology Centre, Addenbrooke’s Hospital, University of Cambridge, Cambridge CB2 0QQ, UK.
†To whom correspondence should be addressed. E-mail: kstefans{at}decode.is (K.S.); julius{at}decode.is (J.G.)
See allHide authors and affiliations
Science Translational Medicine 15 Dec 2010: Vol. 2, Issue 62, pp. 62ra92 DOI: 10.1126/scitranslmed.3001513
eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Servicebefore submitting your own eLetter.
Genetic Correction of PSA Values Using Sequence Variants Associated with PSA Levels
By Julius Gudmundsson, Soren Besenbacher, Patrick Sulem, Daniel F. Gudbjartsson, Isleifur Olafsson, Sturla Arinbjarnarson, Bjarni A. Agnarsson, Kristrun R. Benediktsdottir, Helgi J. Isaksson, Jelena P. Kostic, Sigurjon A. Gudjonsson, Simon N. Stacey, Arnaldur Gylfason, Asgeir Sigurdsson, Hilma Holm, Unnur S. Bjornsdottir, Gudmundur I. Eyjolfsson, Sebastian Navarrete, Fernando Fuertes, Maria D. Garcia-Prats, Eduardo Polo, Ionel A. Checherita, Mariana Jinga, Paula Badea, Katja K. Aben, Jack A. Schalken, Inge M. van Oort, Fred C. Sweep, Brian T. Helfand, Michael Davis, Jenny L. Donovan, Freddie C. Hamdy, Kristleifur Kristjansson, Jeffrey R. Gulcher, Gisli Masson, Augustine Kong, William J. Catalona, Jose I. Mayordomo, Gudmundur Geirsson, Gudmundur V. Einarsson, Rosa B. Barkardottir, Eirikur Jonsson, Viorel Jinga, Dana Mates, Lambertus A. Kiemeney, David E. Neal, Unnur Thorsteinsdottir, Thorunn Rafnar, Kari Stefansson
Science Translational Medicine : 62ra92
Sequence variants in the human genome are associated with serum levels of prostate-specific antigen.
Genetic Correction of PSA Values Using Sequence Variants Associated with PSA Levels
By Julius Gudmundsson, Soren Besenbacher, Patrick Sulem, Daniel F. Gudbjartsson, Isleifur Olafsson, Sturla Arinbjarnarson, Bjarni A. Agnarsson, Kristrun R. Benediktsdottir, Helgi J. Isaksson, Jelena P. Kostic, Sigurjon A. Gudjonsson, Simon N. Stacey, Arnaldur Gylfason, Asgeir Sigurdsson, Hilma Holm, Unnur S. Bjornsdottir, Gudmundur I. Eyjolfsson, Sebastian Navarrete, Fernando Fuertes, Maria D. Garcia-Prats, Eduardo Polo, Ionel A. Checherita, Mariana Jinga, Paula Badea, Katja K. Aben, Jack A. Schalken, Inge M. van Oort, Fred C. Sweep, Brian T. Helfand, Michael Davis, Jenny L. Donovan, Freddie C. Hamdy, Kristleifur Kristjansson, Jeffrey R. Gulcher, Gisli Masson, Augustine Kong, William J. Catalona, Jose I. Mayordomo, Gudmundur Geirsson, Gudmundur V. Einarsson, Rosa B. Barkardottir, Eirikur Jonsson, Viorel Jinga, Dana Mates, Lambertus A. Kiemeney, David E. Neal, Unnur Thorsteinsdottir, Thorunn Rafnar, Kari Stefansson
Science Translational Medicine : 62ra92
Sequence variants in the human genome are associated with serum levels of prostate-specific antigen.
